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Summary
The Siah family of RING proteins function as ubiquitin
ligase components, contributing to the degradation of
multiple targets involved in cell growth, differentiation,
angiogenesis, oncogenesis, and inflammation. Previ-
ously, a binding motif (degron) was recognized in
many of the Siah degradation targets, suggesting
that Siah itself may facilitate substrate recognition.
We report the crystal structure of the Siah in complex
with a peptide containing the degron motif. Binding is
within a groove formed in part by the zinc fingers and
the first two b strands of the TRAF-C domain of Siah.
We show that residues in the degron, previously
described to facilitate binding to Siah, interact with
the protein. Mutagenesis of Siah at sites of interaction
also abrogates both in vitro peptide binding and desta-
bilization of a known Siah target.
Introduction
Protein polyubiquitylation functions as a signal for pro-
tein degradation by the 26S proteasome. One mecha-
nism of protein ubiquitylation involves three steps:
activation of ubiquitin by an E1 enzyme, transfer to
a carrier protein (E2), and ligation to the target in the pres-
ence of a ligase protein-complex (E3). The E2 and, more
especially, the E3 proteins confer specificity for targeting
ubiquitylation (Ciechanover, 1998).
Drosophila SINA (Seven in Absentia) and mammalian
Siah (Seven in Absentia Homolog) are RING-containing
proteins that function in protein degradation as parts of
ubiquitin ligase (E3) components. In Drosophila, SINA
has been shown to cooperate with Phyllopod (PHYL),
Ebi, and UBCD1 to facilitate the ubiquitylation and deg-
radation of the transcriptional corepressor Tramtrack
88 (TTK88) (Boulton et al., 2000; Dong et al., 1999;
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a similar complex comprising Siah1, Siah-interacting
protein (SIP), and the F-box protein, Ebi, bind to adeno-
matous polyposis coli (pAPC) to facilitate the ubiquityla-
tion and degradation of b-catenin via a p53-dependent
mechanism (Matsuzawa and Reed, 2001). As well, Siah
has been reported to bind directly to many proteins
that are subsequently degraded, suggestive of a simpler
E3 complex (Conaway et al., 2002). Structurally, little is
known about the E3 complexes formed with this family
of proteins. It has been suggested that they form a novel
complex similar to, but distinct from, the generic RING-
containing E3 complexes characterized by the anaphase-
promoting complex (APC) and the Skp1/Cul1/F-box
protein (SCF) ligases. The Siah protein’s dimeric nature
alone suggests a variant complex, since none of the
described complexes contain dimeric RING proteins.
Siah has recently received a great deal of attention be-
cause of its role in certain disease processes. For exam-
ple, Siah regulates hypoxia-inducible factor-1a protein
levels, itself a central regulator of the cellular response
to hypoxia by hypoxia-induced interaction and degrada-
tion of PHD prolyl hydroxylases (Nakayama et al., 2004).
Siah also interacts with synphilin-1 and a-synuclein and
thus may play a role in Parkinson’s Lewy body formation
(Liani et al., 2004).
Siah is a dimeric protein consisting of an N-terminal
RING domain followed by two novel zinc finger motifs
and a C-terminal substrate binding domain (SBD). We
have previously determined the crystal structure of
Siah (missing the RING domain) to 2.6 A˚ resolution (Pole-
khina et al., 2002). Analysis of the surface of the molecule
suggested a number of regions that might interact with
protein ligands. The dimer has two deep clefts located
adjacent to the N-terminal zinc fingers of each monomer
and a larger but shallower groove centered about the
dimer interface. We hypothesized that the clefts might
be filled by the RING domains that are N-terminal to the
zinc fingers in the intact Siah molecule. The large shallow
groove (30 A˚ wide), constructed from a curved, antiparal-
lel b sheet that straddles the dimer interface, was consid-
ered as an alternative location for a protein-protein inter-
action region. Reed and Ely (2002) noted that the deep
clefts have an overall electropositive potential, whereas
the shallow groove was strikingly electronegative. Muta-
genesis of carboxylate residues (Glu161, Asp162, Glu226,
Glu237) in the shallow groove of Siah resulted in loss of
binding to the Siah-interacting protein, SIP, whereas
mutations of basic residues in the deep clefts (Arg124,
Arg214, Arg215, Arg231, Arg232) had no effect (Matsu-
zawa et al., 2003). Interestingly, the binding of another
Siah ligand, BAG1, was unaffected by mutations in either
groove or cleft (Matsuzawa et al., 2003). More recently,
we reported that many Siah binding proteins contain
a common binding motif that may act as a degradation
signal or ‘‘degron’’ (House et al., 2003). The residues
within the motif were defined as Arg-Pro-Val-Ala-X-Val-
X-Pro-X-X-Arg, with Pro-X-Ala-X-Val-X-Pro and, espe-
cially, Val-X-Pro constituting the core residues with high-
est conservation.
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a degron motif-containing peptide that reveals a binding
site for Siah-interacting proteins. This site is distinct
from those previously hypothesized as protein interac-
tion sites. We further show that mutation of Siah resi-
dues seen to interact with the degron abrogate binding
to peptide, as well as stabilizing protein in cotransfec-
tion experiments.
Results
Structure of Siah Bound to PHYL Peptide
We have determined the crystal structure of Siah (resi-
dues 92–282) in complex with the synthetic peptide en-
compassing residues 107–130 of PHYL (Figure 1), which
includes the earlier identified common degron motif
(House et al., 2003). The structure of the complex was
determined by molecular replacement using the previ-
ously published Siah (92–282) structure composed of
two zinc fingers and the SBD (Polekhina et al., 2002)
(see Experimental Procedures for a full description).
There are four copies (two dimers, AB and CD) of the
Siah-PHYL complex in the asymmetric unit. The SBDs
of the two dimers superimpose closely with an average
rmsd on Ca’s of 0.3 A˚. Monomers A and C (SBD and fin-
gers) superimpose with an rmsd on Ca’s of 0.45 A˚. How-
ever, the rmsd on superposition of monomers B and D is
much higher (0.9 A˚) due to a shift of the N-terminal zinc
finger domain with respect to each other.
Superposition of the complex structure on the pub-
lished Siah structure reveals no significant conforma-
tional changes beyond movements of the zinc finger
domains and some loops. Superposition of the SBDs
(excluding the loop 195–204 of each monomer, which
have fairly divergent conformations in the complex
structure [see below]) yields an average rmsd on Ca’s
of 0.7 A˚. The zinc finger domains appear more ordered
in the complex structure, likely due to crystal lattice
effects. If the SBDs of the complex and uncomplexed
structures are superimposed, a large shift in the position
of the first zinc finger is observed (5 or 9 A˚, depending on
which monomer is compared) and a small shift (w1.5 to
2 A˚) occurs in the position of the second zinc finger
domain. A loop between residues 172 and 177 adopts
a different conformation in the complex compared to
the uncomplexed structure due to interaction with the
PHYL peptide. However, the conformation of this loop
in all four monomers of the complex structure is very
similar. The loop at the tip of the dimer interface (residues
195–204) adopts a similar conformation in all 4 mono-
mers of Siah, but a different conformation to that of the
uncomplexed structure.
The structure of the complex reveals the PHYL pep-
tide binding site located in a shallow surface groove
formed by the b-sandwich of the Siah SBD and b0 strand
making up the connection between the second zinc fin-
ger domain and SBD (Figure 1). Thus, there are two
PHYL peptide binding sites on the Siah dimer separated
by 45 A˚. The peptide spans a length of 30 A˚ across the
surface of the protein, from the concave surface formed
by the antiparallel b sheet at one end of the dimer to the
tip at the other end of the dimer (Figure 1).Siah-PHYL Peptide Interactions
Good electron density is observed for PHYL residues
114–124. The PHYL peptide adopts an extended confor-
mation, packing against the b1 and b2 strands of the
b sandwich of the Siah SBD (Figure 1). The peptide
makes several parallel b sheet interactions between its
main chain and the main chain atoms of the b1 strand
in Siah: the main chain carbonyl of Pro116 (PHYL) inter-
acts with the main chain amide of Val164; the main chain
amide and carbonyl moieties of Ala118 (PHYL) interact
with the main chain carbonyl of Val164 and the amide
of Leu166; and the main chain amide and carbonyl
moieties of Val120 (PHYL) interact with the main chain
carbonyl moiety of Leu166 and main chain amide of
Thr168. The peptide is also involved in antiparallel
b sheet interactions with the b2 strand of Siah: the
main chain amide and carbonyl moieties of Thr123
(PHYL) interact with the main chain carbonyl and amide
moieties of Asp177 (b2, Siah).
There are a number of contacts involving side chains
(Figures 1B and 1C) that are identical in all four binding
sites observed in the asymmetric unit. Arg115 (PHYL)
is in hydrogen bonding distance with Asp162 and
Asn276. These residues are located in the concave sur-
face formed by the antiparallel b sheet that straddles
the Siah dimer. Val117 (PHYL) is in van der Waals contact
with Val164 (b1, Siah) and Leu166 (b1, Siah). Ala118
(PHYL) is packed against Met180 (b2, Siah) and Leu158
(b0, Siah). The distances between the CB atom of
Ala118 and CE, SD atoms of Met180, and CD2 atom
of Leu158 are 3.4, 3.7, and 4.1 A˚, respectively. Val120
(PHYL) is in van der Waals contact with Phe165 (b1,
Siah), Met180 (b2, Siah), and Trp178 (b2, Siah). The dis-
tances between the CG2 atom of Val120 and the CD2
atom of Phe165, the CB atom of Val120 and the
CE2 atom of Phe165, the CG1 atom of Val120 and the
CB atom of Trp178, the CG2 atom of Val120 and the CB
atom of Met180 are 4.2, 4.5, 4.2, and 3.8 A˚, respectively.
The binding pockets for Ala118 and Val120 are too small
to accommodate larger side chains. Pro122 (PHYL)
packs against Trp178 (b2, Siah), a residue that is strictly
conserved in the Siah/Sina family of proteins.
There are a number of local changes observed in the
Siah structure upon PHYL binding. The b0 strand shifts
by about 1.5 A˚ away from the core of SBD. The side chain
conformation of Phe165 is altered, as manifested by
a change in its chi-2 angle from about 50º to 180º. This,
in turn, causes the side chain of Leu191 to swing out of
the way. The side chain orientation of Leu158 is also
altered to accommodate Ala118 of the PHYL peptide.
The same changes are seen in all four monomers in the
asymmetric unit.
Mutation of Siah Residues that Interact with PHYL
Abrogates Binding to PHYL In Vitro
We used the crystal structure of the complex as a guide
for mutagenesis studies in order to determine the rela-
tive importance of various interacting residues of Siah
with its degron target (PHYL). We mutated Met180 to
Lys to disturb the hydrophobic pocket harboring
Ala118 and Val120 of PHYL in the complex (Figure 1C).
We also targeted residues located in b0 (Thr156 and
Leu158) and b1 (Leu166, Thr168), as well as the residue
Ala175 from the loop 172–177 to probe the role of PHYL
Substrate Binding Site of Siah Ubiquitin Ligase
697Figure 1. Structure of the Siah-PHYL Com-
plex
(A) Stereoview of the two dimers observed in
the asymmetric unit in ribbon style, with the
PHYL peptide shown in stick fashion. An
omitted Fo–Fc electron density map, calcu-
lated from the final model after the PHYL pep-
tide was excluded and contoured at 2s, is
shown in light blue. This figure was prepared
with Bobscript (Esnouf, 1999) and rendered
with RASTER3D (Merritt and Murphy, 1994).
(B and C) Stereoviews showing the key inter-
actions between the PHYL peptide (residues
underlined) and Siah. The brown dashed loop
represents the conformation of the 172–177
loop observed in the uncomplexed Siah struc-
ture.residues 125–130 in the binding (Figure 1B). Leu158Lys,
Leu158Asp, Thr168Arg, Leu166Lys, Ala175Glu, as well
as the double mutations Thr156Glu/Leu158Asp and
Leu166Lys/Thr168Arg, were prepared.
The effects of the mutations were tested in vitro in pull-
down assays with immobilized binding peptide (Figures
2A and 2B). Met180Lys almost completely abolished
binding of the target by Siah, underlying the importance
of the hydrophobic interaction observed in the crystal
structure, and suggesting that it is a key recognition/specificity point. The mutations in strand b0 had more
pronounced effects than the mutations in b1. The side
chains of the residues from strand b0 point into the
PHYL binding groove of Siah.
Effects of Siah Mutants on TIEG-1 Protein Levels
To examine whether the identified binding site is also
responsible for the binding-induced degradation of
reported Siah targets in mammalian cells, we exam-
ined protein levels of the Siah substrate TIEG-1 in
Structure
698Figure 2. Binding Groove Mutants of Siah Fail to Bind PHYL Peptide or Functionally Interact with TIEG-1 in Cotransfection Experiments
(A) Wild-type Siah1a SBD and various binding groove mutants were tested in GST pull-down experiments with GST-PHYL (108–130) resin, as
described in Experimental Procedures. In parallel, GST alone was used but did not bind Siah wild-type or mutants (data not shown).
(B) Quantitation of GST pull-down experiments, as shown in (A). Coomassie stained gels were scanned and quantitated (error bars represent61
SEM; n = 4).
(C) Wild-type HA-Siah1a (50 ng) and binding groove mutants (50 ng) were cotransfected with Flag-TIEG-1 (500 ng) into HEK293T cells. Flag-TIEG-
1 protein levels were detected by Western blotting and quantitated as described in Experimental Procedures.
(D) Relative Flag-TIEG-1 protein levels observed with wild-type and mutant HA-Siah1a cotransfection are plotted (error bars represent61 SEM;
n = 5).cotransfection experiments. The transcriptional repres-
sor, TIEG-1, is a mammalian degradation target for
Siah (Johnsen et al., 2002) that also possesses the con-
sensus degron motif (House et al., 2003). To investigate
the relevance of the peptide binding site to interaction
with TIEG-1, cotransfection experiments were per-
formed in mammalian HEK293T cells. Siah was shown
to reduce protein levels of TIEG-1 when cotransfected
(Figures 2C and 2D). When mutant Siah was introduced
in these experiments, TIEG-1 disappearance was af-
fected to varying degrees, mirroring the pull-down assay
results (Figures 2A and 2B). In particular, mutations in b1
strand of Siah involving residues Leu166 and Thr168 that
only partly disrupted PHYL binding (Figure 2) also re-
duced TIEG-1 protein levels (Figure 3A). Siah mutants
at Met180 and Leu158, which bound PHYL peptide
poorly (Figure 2A), had little effect on TIEG-1 levels
(Figure 2C). In fact, these mutations increased TIEG-1
stability slightly, perhaps acting in a dominant negative
manner within dimers formed with endogenous Siah.
The TIEG-1 destabilization was shown to be proteasome
dependent by the addition of the proteasome inhibitor,
MG132 (Figure 3A), with Siah also shown to increase
the level of detectable ubiquitylated TIEG-1 (Figure 3B).
To further substantiate that the TIEG-1 degron motif
binds within the Siah groove, we mutated the important
Val and Pro within the TIEG-1 degron to Asn. We demon-
strated that TIEG-1 protein levels were stable in the
presence of cotransfected Siah, suggesting that there
was no longer a functional interaction between Siah
and TIEG-1 (Figure 3C).Discussion
The structure of the complex between Siah (residues
92–282) and PHYL (residues 107–130) reveals that the
degron recognition site is located in a shallow surface
groove formed by the b sandwich of the Siah SBD and
a b strand that connects the second zinc finger domain
to SBD. This site has not previously been identified as
a possible protein interaction site (although see below).
There are two PHYL peptide binding sites per dimer with
each peptide spanning a length of 30 A˚ across the sur-
face of the protein (Figure 1). The structure provides
a molecular basis for understanding the importance of
the previously published degron motif, Pro-X-Ala-X-
Val-X-Pro13. Pro116, Ala118, Val120, and Pro122 are all
in direct contact with Siah in the complex structure.
Ala118 and Val120 embed their side chains into the hy-
drophobic core of the b sandwich where the binding
pockets are too small to accommodate larger side
chains. Pro116 and Pro122 ensure the extended confor-
mation of the motif for optimal presentation of the main
chain carbonyls and amides of PHYL to the backbone
atoms of the b strands of Siah. Pro122 also packs
against the conserved Siah residue Trp178.
In the Siah-PHYL complex crystal structure we only
observed electron density corresponding to 114–124
of PHYL even though the peptide used in the crystalliza-
tion included residues 107–130. Thus, residues 108–113
and 125–130 were flexible and could not be modeled.
Residues outside the core degron motif (PXAXVXP) (as
defined by House et al., 2003) that do interact with
Substrate Binding Site of Siah Ubiquitin Ligase
699Figure 3. Flag-TIEG-1 Protein Levels Are
Controlled by Ubiquitylation/Degradation
(A) HEK293T cells were transfected with 500
ng Flag-TIEG-1, plus and minus 25 ng HA-
Siah1a, in the presence and absence of the
proteasomal inhibitor, MG132.
(B) HA-ubiquitylation of Flag-TIEG-1 is in-
creased in the presence of cotransfected
HA-Siah1a in HEK293T cells. The degree of
ubiquitylation of immunoprecipitated Flag-
TIEG-1 was assessed in Western blots de-
tecting cotransfected, HA-tagged ubiquitin.
(C) TIEG-1 Val-X-Pro Siah binding motif af-
fects detectable Flag-TIEG-1 protein levels.
HEK293T cells were transfected with 500 ng
Flag-TIEG-1 or Flag-TIEG-1 (VxP to NxN),
and 6.25–100 ng HA-Siah1a. TIEG-1 levels
were monitored by Western blot probing
with anti-Flag antibody. Due to instability,
Siah1a immunoreactivity was not detected
reproducibly at or below 100 ng of DNA trans-
fected.Siah include Arg115 and Thr123. Arg115 interacts with
an acidic patch on Siah’s concave surface involving res-
idue Asp162, which was previously implicated in sub-
strate recognition (Matsuzawa et al., 2003) and
Asn276. Modeling suggests that Arg111 or Lys113 could
form a salt bridge to either Glu161 or Glu226. Arg125 on
the C-terminal end of PHYL could form a salt bridge with
Glu194 or Glu197. However, the latter would be ex-
pected to have been disrupted by the Ala175Glu muta-
tion. Mutagenesis of several flanking residues in PHYL,
including Arg115, Val117, and Arg125, results in sub-
stantial reduction in binding (House et al., 2003). More-
over, the PHYL (108–130) peptide has previously been
shown to bind to Siah with an apparent KD value of
176 nM, and competes effectively against many other
Siah binding proteins that possess the consensus de-
gron motif (House et al., 2003). The structure of the
Siah-PHYL complex suggests that arginine residues
that flank the consensus sequence might contribute to
degron binding in an unspecific manner rather than be-
ing critical for the specificity of the substrate recogni-
tion. The high affinity binding of PHYL to Siah may rep-
resent the adaptor nature of PHYL, whereas the lower
affinity of the mammalian interactors may facilitate free
transfer from Siah to the proteasome.
The peptide binding groove on Siah can now be com-
pared with the binding sites previously elucidated for
structurally similar domains from molecules such as
TRAF (McWhirter et al., 1999; Park et al., 1999, 2000)
and the meprins (Sunnerhagen et al., 2002). While TRAF
was shown to interact with TNF receptor peptide at
b strands 6 and 7, and the meprins have been postulated
to utilize a similar binding site, Siah-PHYL interaction oc-
curs on the opposite face of the molecule (atb0). We have
previously argued that the mode of recognition adopted
by TRAF-like proteins for their ligands is not possible for
SIAH for steric reasons (Polekhina et al., 2002).
The crystal structure of Siah in complex with a peptide
from the low affinity (KD z 11 mM) Siah-interactingpartner SIP has just been reported (Santelli et al., 2005).
As this peptide also contains the consensus degron
motif, many of the key interactions identified in the high-
affinity (KDz 176 nM) Siah-PHYL complex reported here
are retained. Although no Siah mutations were reported
in the work of Santelli et al. (2005), we expect that our re-
sults would be applicable, to a large degree, to the inter-
action of Siah with SIP. An explanation for high-affinity
binding of PHYL to Siah may be the presence of arginine
residues that flank the degron motif in PHYL but are ab-
sent in SIP. There are two acidic patches on Siah (Glu161,
Asp162 and Asp177, Glu194) that could plausibly inter-
act with the flanking arginine residues. In the structure
reported here, PHYL Arg115 interacts with Siah residues
Asp162 and Asn276. Furthermore, modeling studies
suggest that that PHYL residues Arg111, Lys113, and
Arg125 could also interact with the acidic patches as
well (see above).
The TIEG-1 destabilization in the presence of cotrans-
fected Siah support the suggestion that the PHYL-Siah
interaction defines a binding groove on Siah that is uti-
lized by some mammalian proteins. It is not known at
this stage whether other proteins are recruited to this
complex, or whether Siah itself can facilitate the transfer
of ubiquitin from the E2 to the substrate. It is also not
known whether both binding grooves within a dimer
are utilized, or whether ubiquitin is transferred from an
E2 bound to the same Siah monomer as the substrate.
Further structural experiments, involving larger protein
fragments, will be required to answer these questions.
Experimental Procedures
Expression and Purification of Siah
Mouse Siah 1a (92–282) was cloned into PMCSG7 and expressed as
a His-tag fusion protein in BL21 DE3 Rosetta cells. Protein expres-
sion was induced with 0.1 mM IPTG for 3 hr at room temperature
when the cell density reached an OD600 of 0.6. Siah was purified
on a HisTrap (Invitrogen) column. The His tag was cleaved over 48
hr with a His-tagged TEV protease. TEV, the cleaved His tag, and
Structure
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tion on a HisTrap column. Siah was further purified by Q-Hyper-D
anion exchange in a 0–400 mM NaCl gradient at pH 8.0. Prior to crys-
tallization, the protein was desalted on an NAP-25 column using
a buffer consisting of 25 mM Tris, pH 8.0, and 0.2 mM DTT, and con-
centrated with an Amicon concentrator to 10 mg/ml.
Crystallization of Siah-PHYL Complex
Siah was mixed with a synthetic PHYL peptide 107–130 (Leu-Gln-
Gln-Glu-Arg-Thr-Lys-Leu-Arg-Pro-Val-Ala-Met-Val-Arg-Pro-Thr-Val-
Arg-Val-Gln-Pro-Gln-Leu-NH2 from Auspep, synthesized with free
amino terminus and C-terminal amide, at >95% purity) at a 1:1 ratio
and then incubated for 2 hr at room temperature. Crystallization
was performed at 295K using the hanging-drop vapor-diffusion tech-
nique. Very thin plate-shaped crystals (2 mm 3 2 mm 3 0.03 mm)
grew within a week when 2 ml Siah-PHYL (107–130) was mixed with
an equal volume of reservoir solution containing 100 mM Tris, pH
8.0, 5% (v/v) MPD, 10 mM Tris(2-carboxyethyl)phosphine hydrochlo-
ride (TCEP), and 1.3–1.6 M MgSO4. The presence of PHYL peptide
in the crystals was confirmed by resolving dissolved crystals on
SDS-PAGE.
Structure Determination of Siah1a-PHYL Peptide Complex
Diffraction data were collected at 100K and recorded on a MAR
CCD-165 detector on BioCARS beam line 14-ID-B at the Advanced
Photon Source (Chicago, IL). The wavelength was set to 1.117 A˚, and
10% (v/v) glycerol was used as a cryoprotectant. Data were
processed with the HKL package (Otwinowski and Minor, 1997)
(Table 1). The structure was determined by molecular replacement.
The search model was the Siah dimer (PDB code: 1K2F), excluding
the zinc fingers. Calculations with data to 4 A˚ resolution were per-
formed with the program Molrep (CCP4, 1994). Two solutions were
found that gave an R factor of 52.1% and a correlation coefficient
of 0.46. After four cycles of refinement using REFMAC (Murshudov
et al., 1997) and model rebuilding using O (Jones et al., 1991), the
density corresponding to PHYL peptide could be unambiguously
interpreted to be anchored at Met 119. The final model includes 4
Siah monomers 92–282, including 8 zinc ions and 4 PHYL peptides
(114–124). The stereochemical quality of the final model is good
(Table 1), with 77.6% of residues in the most favored region of the
Ramachandran plot, only 3 residues in the generously allowed re-
gions, and none in the disallowed regions. Other stereochemical
parameters are all better than or within the allowed ranges defined
by PROCHECK (Laskowski et al., 1993).
Mutagenesis Experiments
Siah and TIEG-1 mutants were made using the Stratagene Quik-
Change mutagenesis kit. The mutations were confirmed by restric-
tion enzyme digest and DNA sequencing. The Siah SBD mutants,
in pMalC2 (New England Biolabs), were expressed in BL21 (DE3)
cells by the protocol for wild-type Siah SBD (as maltose binding pro-
tein [MBP] fusions), as published previously (Polekhina et al., 2002),
and purified using amylose resin (New England Biolabs). The MBP
fusion protein was retained for binding assays.
Pull-Down Assays
A 10 ml aliquot of GSH-Sepharose resin (Pharmacia) with bound GST-
PHYL (108–130) was incubated with 0.4mg MBP-Siah-SBD, wild-type
or mutants, for 20 min at 4ºC in binding buffer (25 mM Tris, pH 8.0, 0.2
M NaCl, 15 mM b-mercaptoethanol, 0.1% NP-40). Controls included
GST alone, tested for binding to all mutants, and MBP alone, tested
for binding to GST and GST-PHYL (108–130). After binding, resin
was washed 33 1 ml in binding buffer, then heated in 100 ml Laemmli
sample buffer for 5 min at 95ºC. Ten percent of the sample and 10% of
the input were separately resolved by 15% PAGE and stained with
Coomassie Brilliant Blue R-250. The amount of MBP-Siah-SBD
bound to GST-PHYL (108–130) was quantitated by scanning den-
sitometry using Scion Image software. The measurements were
normalized to Siah input.
TIEG-1 Protein Transfection Experiments
Transfections were performed in 12-well tissue culture plates using
HEK293T cells and Lipofectamine 2000 (Invitrogen), according to the
manufacturer’s instructions. DNA for Flag-TIEG-1 (in pCDNA4/TO),and HA-Siah1a (pCDNA3), were added as shown in the legends for
Figures 2 and 3. After 20–24 hr in culture, cells were washed once
in 1 ml PBS and harvested in SDS sample buffer prior to SDS-
PAGE and Western blotting. Blots were probed with anti-Flag anti-
body (Sigma) for TIEG-1 and anti-HA antibody for Siah and PHYL ex-
pression, with anti-a-tubulin as a loading control. Western blots
were visualized by chemiluminescence, scanned, and quantified
using Scion Image software. For ubiquitylation experiments, a 10
cm dish of HEK293T cells was transfected as above with 2 mg
Flag-TIEG-1, 250 ng HA-Siah1a, and 150 ng HA-ubiquitin (in
pMT123) plasmid DNAs; 20 mM MG-132 was included for the last 6
hr to stabilize ubiquitylated proteins. Cells were lysed in RIPA buffer
(25 mM Tris-HCl, [pH 8.2], 50 mM NaCl, 1% sodium deoxycholate,
1% NP-40, and 0.1% SDS) and Flag-TIEG-1 immunoprecipitated
overnight with 1 mg anti-Flag antibody (Sigma) per 10 cm plate. An-
tibody-protein complexes were pelleted using Protein A/G resin
(Santa Cruz), washed, then boiled in Laemmli sample buffer for
5 min prior to SDS-PAGE and Western blotting. Expression vector
for Flag-TIEG-1 was a gift from Steven Johnsen and Thomas Spels-
burg (Mayo Clinic and Foundation, Rochester, NY). Expression
vector for HA-ubiquitin in pMT123 was a gift from Dr. D. Bohmann
(University of Rochester Medical Center, Rochester, NY).
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Table 1. Data Collection and Refinement Statistics
Native
Data Collection
Space group P21
Cell dimensions
a, b, c (A˚) 63.3, 100.0, 103.4
a, b, g (º) 90.0, 104.3, 90.0
Resolution (A˚) 3.0 (3.1–3.0)
Rmerge 8.2 (50.8)
I/sI 13.0 (1.3)
Completeness (%) 99.2 (95.8)
Redundancy 3.2 (3.0)
Refinement
Resolution (A˚) 3.0
No. reflections 23,606
Rwork/Rfree 23.7/30.2
No. atoms 6,376
Protein 6,024
PHYL peptide/Zn ions 344/8
B-factors
Protein 75.0
Protein (Siah SBD only) 65.7
Protein (Zn finger domains only) 93.2
PHYL peptide/Zn ions 71.4/96.8
Rmsds
Bond lengths (A˚) 0.017
Bond angles (º) 1.8
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